TY - JOUR
T1 - An updated view on stem cell differentiation into smooth muscle cells
AU - Zhang, Li
AU - Zhou, Yijiang
AU - Zhu, Jianhua
AU - Xu, Qingbo
PY - 2012
Y1 - 2012
N2 - Stem cells possess the ability of self-renewal and give rise to specific cell types. The differentiation of stem cells involves environmental factors, transduction of extra and intra-cellular signals, regulation of gene expression by transcriptional factors, microRNAs and chromosome structural modifiers. Vascular SMCs play a profound role in blood vessel physiology and participate in a number of cardiovascular diseases such as atherosclerosis, hypertension and restenosis. In addition, SMCs could be a crucial cell component for vascular tissue engineering. In this review, we aim to update the recent progress on the mechanisms of SMC differentiation from stem cells, which involve reactive oxygen species, epigenetic modifiers, transcription factors and microRNAs coordinately regulated during stem cell differentiation. We will also discuss the potential application of stem cell therapy for patients with cardiovascular diseases. Crown Copyright (C) 2012 Published by Elsevier Inc. All rights reserved.
AB - Stem cells possess the ability of self-renewal and give rise to specific cell types. The differentiation of stem cells involves environmental factors, transduction of extra and intra-cellular signals, regulation of gene expression by transcriptional factors, microRNAs and chromosome structural modifiers. Vascular SMCs play a profound role in blood vessel physiology and participate in a number of cardiovascular diseases such as atherosclerosis, hypertension and restenosis. In addition, SMCs could be a crucial cell component for vascular tissue engineering. In this review, we aim to update the recent progress on the mechanisms of SMC differentiation from stem cells, which involve reactive oxygen species, epigenetic modifiers, transcription factors and microRNAs coordinately regulated during stem cell differentiation. We will also discuss the potential application of stem cell therapy for patients with cardiovascular diseases. Crown Copyright (C) 2012 Published by Elsevier Inc. All rights reserved.
U2 - 10.1016/j.vph.2012.02.014
DO - 10.1016/j.vph.2012.02.014
M3 - Literature review
SN - 1537-1891
VL - 56
SP - 280
EP - 287
JO - VASCULAR PHARMACOLOGY
JF - VASCULAR PHARMACOLOGY
IS - 5-6
ER -